IP20-18: Similar long-term efficacy of reduced-dose induction BCG compared to full-dose induction BCG in the treatment of intermediate- and high-risk non-muscle invasive bladder cancer

IP20-18: Similar long-term efficacy of reduced-dose induction BCG compared to full-dose induction BCG in the treatment of intermediate- and high-risk non-muscle invasive bladder cancer

Friday, May 15, 2026 3:30 PM to 5:30 PM · 1 hr. 59 min. (America/New_York)
146A
Abstract

Log in

See all the content and easy-to-use features by logging in or registering!